Announced goal to produce 4 billion doses of the vaccine against Covid in 2022 By Pfizer Last week, the pharmaceutical company plans to increase the number of factories it has in the world that are involved in immune production from 9 to 20.
Today, Pfizer has six of its own and three in partnership with the German company BioNTech that produces vaccines with this technology. According to the American company, the idea for 2022 is access to eight private factories and 12 units with partnerships.
Infrastructure is not a bottleneck for producing immune systems, Albert Burla, CEO of the pharmaceutical company, recently said in a letter from Pfizer. The limitation, he said, is the scarcity of the inputs used for vaccines. “Currently, nearly every gram of the raw materials produced is immediately sent to our facilities and converted into vaccines,” Burla said.
German heavy machinery manufacturer Berco, from Germany’s Thyssenkrupp, will expand its conveyor belt line for sugarcane harvesting, with new low-cost products in June.
The new line is called Berco Green, and it will be produced in Asia, and not in Italy, like other products of the brand. We are a family owned and operated business.
With Mariana Grazini e Andressa Mutter
Current link: Did you like this column? A subscriber can issue five free accesses from any link per day. Just click the blue F button below.